Eagle Pharmaceuticals Inc
(EGRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 13,308 | 15,698 | 8,973 | 31,903 | 19,313 |
| Depreciation Amortization | 3,651 | 2,453 | 1,227 | 4,046 | 3,116 |
| Income taxes - deferred | -175 | -127 | -287 | -2,468 | 2,040 |
| Accounts receivable | 21,674 | 6,147 | 2,556 | -12,665 | -24,640 |
| Accounts payable and accrued liabilities | 1,315 | 7,379 | 6,869 | -2,064 | -4,437 |
| Other Working Capital | 25,588 | 19,385 | 10,486 | -7,889 | -32,417 |
| Other Operating Activity | -6,174 | -2,362 | -3,643 | 41,521 | 51,301 |
| Operating Cash Flow | $59,187 | $48,573 | $26,181 | $52,384 | $14,276 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -647 | -343 | -177 | -133 | -52 |
| Investing Cash Flow | $-647 | $-343 | $-177 | $-133 | $-52 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -5,000 | -3,750 | N/A | -3,750 | -3,750 |
| Common Stock Issued | 78 | 55 | 42 | 8,615 | 8,601 |
| Common Stock Repurchased | -15,000 | -15,000 | 0 | -73,105 | -22,628 |
| Other Financing Activity | -198 | -198 | -2,698 | -19,877 | -19,878 |
| Financing Cash Flow | $-20,120 | $-18,893 | $-2,656 | $-88,117 | $-37,655 |
| Beginning Cash Position | 78,791 | 78,791 | 78,791 | 114,657 | 114,657 |
| End Cash Position | 117,211 | 108,128 | 102,139 | 78,791 | 91,226 |
| Net Cash Flow | $38,420 | $29,337 | $23,348 | $-35,866 | $-23,431 |
| Free Cash Flow | |||||
| Operating Cash Flow | 59,187 | 48,573 | 26,181 | 52,384 | 14,276 |
| Capital Expenditure | -647 | -343 | -177 | -133 | -52 |
| Free Cash Flow | 58,540 | 48,230 | 26,004 | 52,251 | 14,224 |